For the year ending 2025-12-31, CAPR has $355,949,294 in assets. $50,157,149 in debts. $287,847,312 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 287,847,312 | |||
| Marketable securities | 30,281,603 | |||
| Receivables | 59,167 | |||
| Prepaid expenses and other current assets | 4,751,674 | |||
| Total current assets | 322,939,756 | |||
| Property and equipment, net | 18,312,238 | |||
| Lease right-of-use assets, net | 13,537,820 | |||
| Other assets | 1,159,480 | |||
| Total assets | 355,949,294 | |||
| Accounts payable | 1,654,754 | |||
| Accrued expenses | 15,557,646 | |||
| Lease liabilities, current | 202,376 | |||
| Cirm liability, current | 6,421,984 | |||
| Deferred revenue, current | 12,000,000 | |||
| Total current liabilities | 35,836,760 | |||
| Cirm liability, net of current | 0 | |||
| Lease liabilities, net of current | 14,320,389 | |||
| Total long-term liabilities | 14,320,389 | |||
| Total liabilities | 50,157,149 | |||
| Common stock, 0.001 par value, 100,000,000 shares authorized, 57,370,909 and 45,582,288 shares issued and outstanding, respectively | 57,371 | |||
| Additional paid-in capital | 610,330,105 | |||
| Accumulated other comprehensive income | 283,154 | |||
| Accumulated deficit | -304,878,485 | |||
| Total stockholders' equity | 305,792,145 | |||
| Total liabilities and stockholders' equity | 355,949,294 | |||
CAPRICOR THERAPEUTICS, INC. (CAPR)
CAPRICOR THERAPEUTICS, INC. (CAPR)